Enzytec supports Medmax in obtaining ANVISA's Good Manufacturing Practices for In Vitro Diagnosis
Enzytec, with its Regulatory Affairs team, provided consulting services to MEDMAX, a company that produces equipment and reagents for In Vitro diagnostics, with the aim of adapting its manufacturing unit to comply with Good Control and Manufacturing Practices according to RDC 16/2013 – ANVISA.
With the support of the MEDMAX technical and quality team coordinated by Letícia Lopes and Rafael Barbosa, all adjustments, process and procedure reviews were carried out, in addition to the audit, which guaranteed the certificate to the company on September 29, 2021.
Enzytec appreciates the trust in its services and in being part of the team responsible for this achievement. Now we have another qualified enterprise in the health area in Brazil!